Cargando…

Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy

BACKGROUND: Kidney injury molecule-1 (KIM-1) is a biomarker useful for detecting early tubular damage and has been recently reported as a useful marker for evaluating kidney injury in IgA nephropathy (IgAN). We therefore investigated whether treatment decreases urinary KIM-1 excretion in IgAN. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Mi Seon, Park, Moo Yong, Choi, Soo Jeong, Jeon, Jin Seok, Noh, Hyunjin, Kim, Jin Kuk, Han, Dong Cheol, Hwang, Seung Duk, Jin, So Young, Kwon, Soon Hyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717021/ https://www.ncbi.nlm.nih.gov/pubmed/23837450 http://dx.doi.org/10.1186/1471-2369-14-139

Ejemplares similares

IgA nephropathy is associated with elevated urinary mitochondrial DNA copy numbers
por: Yu, Byung Chul, et al.
Publicado: (2019)

Validation of the Oxford Classification of IgA Nephropathy: A Single-Center Study in Korean Adults
por: Lee, Hoyoung, et al.
Publicado: (2012)

Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy
por: Hwang, Dohui, et al.
Publicado: (2021)

Urinary C5b-9 as a Prognostic Marker in IgA Nephropathy
por: Yu, Byung Chul, et al.
Publicado: (2022)

Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy
por: Yoon, Soo-Young, et al.
Publicado: (2023)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Complete remission of IgA nephropathy after bone marrow transplantation for acute myeloid leukaemia
por: Park, Eun-Kyung, et al.
Publicado: (2008)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Jin Sug, et al.
Publicado: (2020)

Noninvasive Urinary Monitoring of Progression in IgA Nephropathy
por: Yang, Joshua Y. C., et al.
Publicado: (2019)

Urinary peptidome analysis in CKD and IgA nephropathy
por: Li, Zewen, et al.
Publicado: (2023)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Urinary miRNA profile for the diagnosis of IgA nephropathy
por: Szeto, Cheuk-Chun, et al.
Publicado: (2019)

Beta-Thalassemia Minor Is Associated with IgA Nephropathy
por: Kang, Jung Hyun, et al.
Publicado: (2013)

Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease
por: Cho, Won-Hee, et al.
Publicado: (2020)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status
por: Gong, Shaomin, et al.
Publicado: (2021)

Clinical value of pathologic examination of non-neoplastic kidney in patients with upper urinary tract malignancies
por: Wee, Jee Wan, et al.
Publicado: (2016)

Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy
por: Wang, Gang, et al.
Publicado: (2010)

Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy
por: Seki, Takuto, et al.
Publicado: (2014)

Elevated Urinary IL-6 Predicts the Progression of IgA Nephropathy
por: Zhao, Wenjun, et al.
Publicado: (2022)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAκ deposits: a pattern switch
por: Li, Jin-pu, et al.
Publicado: (2023)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Clinical manifestations of IgA nephropathy combined with thin glomerular basement membrane nephropathy in children
por: Ju Hwang, Young, et al.
Publicado: (2013)

Iron metabolism and chronic inflammation in IgA nephropathy
por: Tian, Zhang-yu, et al.
Publicado: (2023)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Hypertriglyceridemia Is Associated with More Severe Histological Glomerulosclerosis in IgA Nephropathy
por: Choi, Won Jung, et al.
Publicado: (2021)

The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy
por: Kim, Hyoungnae, et al.
Publicado: (2019)

Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy
por: Wang, Nannan, et al.
Publicado: (2015)

Urinary CXCL1: A Novel Predictor of IgA Nephropathy Progression
por: Zhao, Yanfeng, et al.
Publicado: (2015)

Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy
por: Duan, Zhi-Yu, et al.
Publicado: (2016)

Association between urinary VEGFA and renal pathology of IgA nephropathy patients
por: Feng, Shaozhen, et al.
Publicado: (2021)

The Impact of Obesity on the Severity of Clinicopathologic Parameters in Patients with IgA Nephropathy
por: Hong, Yu Ah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_be9socbp4ebjmr1s56gs2tbq46